SCHEMBL26259327

SCHEMBL26259327

COc1ccc2c(-c3ccco3)c(OC)ccc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 1/20 0.57
▸ MAPT P10636 4/20 0.49
▸ KDM4E B2RXH2 4/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ POLB P06746 3/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ HPGD P15428 3/20 0.49
▸ ALOX12 P18054 2/20 0.49
▸ RECQL P46063 2/20 0.49
▸ MCL1 Q07820 2/20 0.49
▸ THRB P10828 1/20 0.49
▸ PTPN7 P35236 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ BLM P54132 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ NPC1 O15118 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25666398 0.86 PLAU (0.57) PLAUMAPTKDM4EALDH1A1POLB
SCHEMBL26259632 0.83 PLAU (0.58) PLAUMAPTKDM4EALDH1A1POLB
SCHEMBL25666341 0.82 MAPT (0.66) PLAUMAPTKDM4EALDH1A1POLB
SCHEMBL26259490 0.79 RAB9A (0.47) PLAUMAPTKDM4EALDH1A1POLB
SCHEMBL25666349 0.76 MAPT (0.56) MAPTKDM4EALDH1A1RAB9AMEN1
SCHEMBL25667075 0.75 PLAU (0.51) PLAUMAPTKDM4EALDH1A1POLB
SCHEMBL7338518 0.74 PLAU (0.60) PLAUMAPTKDM4EALDH1A1POLB
SCHEMBL3685709 0.72 CYP3A4 (0.54) MAPTKDM4EALDH1A1POLBRAB9A
SCHEMBL28454998 0.71 ALDH1A1 (0.51) MAPTKDM4EALDH1A1RAB9AMEN1
SCHEMBL26259328 0.71 MEN1 (0.51) MAPTKDM4EALDH1A1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 PLAU 2979/4885MAPT 89/4885KDM4E 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback